The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Taiho Pharmaceutical
A phase II trial of panitumumab with irinotecan and S-1 (IRIS) as second-line treatment in patients with wild-type KRAS metastatic colorectal cancer.
 
Rai Shimoyama
No Relationships to Disclose
 
Tetsuo Kimura
No Relationships to Disclose
 
Toshi Takaoka
No Relationships to Disclose
 
Kazuki Sakamoto
No Relationships to Disclose
 
Shunji Kawamoto
No Relationships to Disclose
 
Koji Yoshizaki
No Relationships to Disclose
 
Yuji Negoro
No Relationships to Disclose
 
Fuminori Goda
No Relationships to Disclose
 
Akihito Tsuji
No Relationships to Disclose
 
Tsuyoshi Nakayama
No Relationships to Disclose
 
Hiroshi Miyamoto
No Relationships to Disclose
 
Tetsuji Takayama
No Relationships to Disclose
 
Yoshiro Niitsu
No Relationships to Disclose